Back to Aberdeen Group plc Aberdeen Group plc

LLYLLY

Showing 8 of 30 quarters

Position history for Aberdeen Group plcAberdeen Group plc's holdings in Eli Lilly and Company

Yes. Aberdeen Group holds 682,818 shares of LLY (Eli Lilly), worth $819M, as of its Q2 2026 13F filing. It reduced the position by 41,535 shares (-5.7%) from Q1 2026. Aberdeen Group has held LLY in every 13F on record since Q1 2019, 30 quarterly filings. LLY is 1.1% of Aberdeen Group's reported 13F portfolio.

Current Value

$819M

Current Shares

682,818

Total Value Change

-$29.6M

Total Shares Change

-284,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
682,818
-5.7%
$819M1.1%$1,197.71
0
2026-Q1
Decreased
724,353
-3.1%
$666.2M1.1%$916.88
0
2025-Q4
Decreased
747,227
-11.6%
$803M1.2%$1,069.51
0
2025-Q3
Decreased
845,003
-5.5%
$618.3M1.0%$758.22
0
2025-Q2
Decreased
893,856
-2.2%
$695.1M1.2%$772.95
0
2025-Q1
Decreased
914,176
-2.2%
$741.7M1.4%$817.26
0
2024-Q4
Decreased
934,559
-3.3%
$716M1.3%$762.60
0
2024-Q3
Decreased
966,818
-7.9%
$848.6M1.6%$873.71
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used